Search the Newsreel

Suzano S.A. Revenue Breakdown – BMFBOVESPA:SUZB3

Suzano S.A. (SUZB3) generated 50.12 billion BRL last year, with its top-performing Cellulose segment contributing 37.82 billion BRL. The largest regional contribution came from China, accounting for 14.16 billion BRL of the company's revenue.

Suzano S.A. ADR Cert Deposito Arg Repr 1 Sp ADR Revenue Breakdown – BCBA:SUZ

This article provides a revenue breakdown for Suzano S.A. ADR (BCBA:SUZ), highlighting its top-performing segment and geographical contributions. In the last year, the company generated 13.25 trillion ARS, with the Cellulose segment contributing 9.99 trillion ARS. China was the largest geographical contributor, accounting for …

Suzano SA (SUZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Suzano SA (SUZ), categorizing its income by business segments and geographic regions. The data, updated on April 6th, shows "Cellulose" as the dominant business segment and "Asia" as the leading regional contributor to the company's revenue.

Suzano SA (SUZ) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Suzano SA's (SUZ) dividend history, detailing dividend distribution dates, amounts, and ex-dividend dates. It highlights that Suzano SA has distributed a total of $1.15 billion in dividends over the past five years. The page also includes current stock …

Celularity Inc. (CELU) Q4 2025 Earnings: Narrower-Than-Expected Loss as Operational Discipline Improves - Slow Growth Warning

Celularity Inc. (CELU) warrants delisted and deregistered from Nasdaq exchange

Celularity Inc. (CELU) warrants have been delisted and deregistered from the Nasdaq Stock Market LLC. This action, initiated by Nasdaq, signifies that the warrants will have reduced public market visibility and liquidity. The delisting complies with Section 12(b) of the Securities Exchange Act of …

Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU)

Suzano S.A. (SUZ) Releases Q1 2026 Earnings: Revenue Up but Net Income and EPS Down | SUZ Stock News

There Is A Reason Celularity Inc.'s (NASDAQ:CELU) Price Is Undemanding

Celularity Inc SEC 10-Q Report

CELU: Revenue up 138% to $54.2M, but severe liquidity and delisting risks threaten Celularity's future

CELU: Revenue surged 138% in 2024 as Celularity's biomaterial products fueled strong growth

Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting

Celularity’s Breakthroughs in Cellular Therapy and Revenue Growth: Highlights from the R&D Day

Celularity Inc. (CELU) Stock Forecast & Price Prediction 2026–2030

Celularity (NASDAQ:CELU) shareholders have endured a 65% loss from investing in the stock a year ago